Abstract A 68-year-old man with no symptoms presented to Hokkaido University Hospital for esophagogastroduodenoscopy screening. He had a history of Helicobacter pylori eradication. Initial esophagogastroduodenoscopy showed no gastric cobblestone-like mucosa or gastric cracked mucosa. After 1 year, he received esomeprazole (20 mg) once daily for heartburn at another hospital. Esophagogastroduodenoscopy was performed after 2 years of esomeprazole administration. Endoscopic findings showed that after H. pylori eradication, according to the Kyoto classification, gastric cobblestone-like mucosa presented in the gastric body area. Dilation of the oval crypt opening and intervening part in the gastric cobblestone-like mucosa was detected by endoscopy with narrow band imaging. Endoscopic ultrasonography revealed a thick gastric second layer and sporadic small a-echoic lesions in the low-echoic thickened second layer in the gastric cobblestone-like mucosa. The gastric cobblestone-like mucosa biopsy specimen showed parietal cell protrusions and oxyntic gland dilatations. Recently, we reported that gastric mucosal changes such as gastric cracked mucosa and gastric cobblestone-like mucosa were caused by protonpump inhibitors; however, the gastric cobblestone-like mucosa was not examined by endoscopic ultrasonography. In this case, endoscopic ultrasonography findings suggested that oxyntic gland dilatations caused the elevated gastric mucosa, such as gastric cobblestone-like mucosa, from the use of proton-pump inhibitors.
Introduction
Proton-pump inhibitors (PPIs) strongly inhibit the function of H ? /K ? -ATPase in gastric parietal cells and suppress the secretion of gastric acid. PPIs are widely available for acidrelated disorders such as gastric or duodenal ulcers and gastroesophageal reflux disease. The use of PPIs is increasing [1] . In addition, high rates of long-term PPI use are reported [1, 2] . The long-term use of PPIs is related to some side effects such as enteric infections [3] and fractures [4] . The development of fundic gland polyps results from a trophic effect on parietal cells with PPI use [5, 6] . In addition, it was reported that gastric black spots and white flat elevated lesions appeared in a patient taking PPIs [7, 8] . Pathologically, parietal cell protrusions and oxyntic gland dilatations occur in patients using PPIs [9, 10] . Recently, we reported that gastric mucosal changes such as gastric cobblestone-like mucosa (GCSM) and gastric cracked mucosa (GCM) were caused by PPIs [11] . GCSM is defined as gastric mucosa that has a cobblestone-like appearance and is endoscopically detected as multiple smooth elevated mucosa. GCM is defined as gastric mucosa that has a crackled-like appearance and is endoscopically detected as multiple depressed lines. GCSM and GCM were detected in 9.1 and 24.4% of patients receiving PPIs. These mucosal changes appeared only in the gastric corpus area and were associated with oxyntic gland dilatations. It was assumed that oxyntic gland dilatations led to mucosal elevation, that slight oxyntic gland dilatations in the gastric mucosa appeared to be GCM and that more substantial dilatations appeared to be GCSM. However, endoscopic ultrasonography (EUS) of GCSM has not been reported. In this case, we examined GCSM by EUS.
Case report
A 68-year-old man with no symptoms presented to Hokkaido University Hospital for esophagogastroduodenoscopy (EGD) screening. He had a history of Helicobacter pylori eradication. Initial EGD showed no GCSM or GCM (Fig. 1a,  b) . After 1 year, he received esomeprazole (20 mg) once daily for heartburn at another hospital. EGD was performed after 2 years of esomeprazole administration. Endoscopic findings showed that after the eradication of H. pylori according to the Kyoto classification [8] , i.e. atrophic changes in the antrum (Fig. 2a) , there was no regular arrangement of collecting venules in the gastric angle ( Fig. 2b ) and there were no atrophic changes in the body area (Fig. 2c) . The patient was negative for all H. pylori tests, including the 13 C-urea breath test (Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan), rapid urease test (Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan), H. pylori IgG E-plate (Eiken Chemical Co., Ltd., Tokyo, Japan), and culture. For histological examination, gastric biopsy tissues of the antrum showed moderate atrophy; however, tissues of the body area showed no atrophy. Both tissues showed no H. pylori. Serum gastrin level was 678 pg/ml, serum pepsinogen (PG) I level was 222 ng/ml, and serum PGII level was 36.2 ng/ml. In this patient, GCSM presented in the gastric body area (Fig. 2d, e) . Endoscopic findings with narrow band imaging (NBI) showed dilation of the oval crypt opening and the intervening part in the GCSM (Fig. 2f) . EUS using a 20-MHz probe (UM-G20-29R; Olympus Co, Tokyo Japan) with an ultrasound processor (EU-ME1; Olympus Co, Tokyo Japan) for the GCSM revealed a thick gastric second layer and sporadic small a-echoic lesions in the low-echoic thickened second layer (Fig. 3) . A GCSM biopsy specimen showed parietal cell protrusions (PCPs) and oxyntic gland dilatations (Fig. 4a, b) . There was no fibrosis, hypervascularity, or inflammatory cell infiltration.
Discussion
We performed EUS for the GCSM and examined the gastric mucosa. EUS showed sporadic small a-echoic lesions in the low-echoic thickened second layer. Histologically, PCPs and oxyntic gland dilatations were detected in the tissue of the GCSM. Parietal cell protrusions and oxyntic gland dilatations result from PPI use [9] . PPIs increase the number of parietal cells by expressing aquaporin-4, which forms membrane water channels [12] . Therefore, these histological changes might be caused by the movement of water from the interstitial space toward the lumen of oxyntic glands. Kumar et al. demonstrated that oxyntic gland dilatation is associated with PPI use only in patients without H. pylori infection [9] . Similarly, fundic gland polyps developed from long-term PPI use in a patient without H. pylori infection [5] . Recently, we reported that gastric mucosal changes such as GCM and GCSM result from the use of PPIs in a patient without current H. pylori infection [11] .
In our case, the patient had a history of H. pylori eradication and tests for H. pylori were all negative. Endoscopically and histologically, atrophic changes presented in only the gastric antrum area. Therefore, oxyntic glands remained in the body area and were dilated by PPIs. Endoscopic findings with NBI showed dilation of the oval crypt opening and intervening part. In addition, EUS showed a thick second layer and sporadic small low-echoic lesions. Histologically, many dilated fundic glands with PCPs were detected, and the major axis of the lumen of the most dilated fundic gland was 360 lm. The normal fundic glands exhibit no PCPs and were not dilated. The major axis of the lumen of the normal fundic gland is usually \50 lm [11] . Large-size oxyntic gland dilatations were detected by EUS as sporadic small a-echoic lesions. Therefore, these NBI and EUS findings suggest that Fig. 3 Endoscopic ultrasonography (EUS) for the gastric cobblestone-like mucosa. EUS with a 20-MHz probe showed mucosal elevation in the thick second layer (red color arrows) and sporadic, small a-echoic lesions (yellow color arrows) in the second layer Fig. 4 The gastric cobblestonelike mucosa biopsy specimen showed parietal cell protrusions and oxyntic gland dilatations. a Hematoxylin and eosin, original magnification, 1009, Scale bars 500 lm. b Hematoxylin and eosin, original magnification, 4009, Scale bars 50 lm oxyntic gland dilatations caused the elevated gastric mucosa.
A limitation of this case is that features of EUS findings were compared only with those of biopsy specimens.
In conclusion, we presented the EUS features of GCSM, such as small a-echoic lesions in the low-echoic thickened second layer. These EUS findings support PPI use as the cause of GCSM development. In addition, given that the number of patients taking anticoagulants has been increasing, EUS is helpful for diagnosing GCSM in case of biopsy difficulties. Human Rights: All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed Consent: Informed consent was obtained from this patient for being included in the study.
